What it sells
Operating system for AI-ready labs.
Business model breakdown
Buyer: who owns the budget?
UnverifiedHeads of lab automation, R&D or core facilities at pharma, biotech, hospital and research labs.
Workflow: what inputs become what output?
Scientists and automation engineers design workflows on the node-based LINQ Canvas or Python SDK, the scheduler runs parallel workflows across any vendor's instruments with live monitoring, and data flows to any ELN/LIMS; applications include genomics, cell culture, ELISA, LC/MS, high-throughput screening.
Economics: what it saves and how it charges
UnverifiedHardware (LINQ Bench) plus software and cloud subscription and service/support contracts; no prices published.
Distribution: how it reaches customers
Direct sales via "Book a meeting" with automation experts; partnerships (e.g., Cellvoyant); offices in UK, US and Germany.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-01-29 | Series C | $45M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.